BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 904002)

  • 21. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of cell-mediated immunity in B77 tumor bearing rats by 51chromium release assay.
    Kalafut F; Novotná L; Valentová N
    Neoplasma; 1981; 28(6):689-95. PubMed ID: 7339497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced lymphocyte-mediated killing of tumour cells after tumour irradiation in vivo.
    Moroson H; Nowakowski J; Schechter M
    Int J Radiat Biol Relat Stud Phys Chem Med; 1978 May; 33(5):473-82. PubMed ID: 306980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential studies of serum blocking activity in rats bearing chemically induced primary bowel tumors.
    Steele G; Sjögren HO; Rosengren JE; Lindström C; Larsson A; Leandoer L
    J Natl Cancer Inst; 1975 Apr; 54(4):959-67. PubMed ID: 1127725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kinetic study of antitumor lymphocyte cytotoxicity in rats bearing progressive or regressive syngeneic colonic tumors].
    Pelletier H; Olsson O; Lagadec P; Reisser D; Jeannin JF
    C R Seances Soc Biol Fil; 1985; 179(5):669-78. PubMed ID: 2938696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated responses in dogs with spontaneous neoplasms. I. Detection of cell-mediated cytotoxicity by the chromium-51 release assay.
    Betton GR; Gorman NT
    J Natl Cancer Inst; 1978 Oct; 61(4):1085-93. PubMed ID: 279712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells.
    Holden HT; Oldham RK; Ortaldo JR; Herberman RB
    J Natl Cancer Inst; 1977 Mar; 58(3):611-22. PubMed ID: 839557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic studies of prostatic cancer using the R3327 rat model.
    Lubaroff DM; Reynolds CW; Culp DA
    Trans Am Assoc Genitourin Surg; 1978; 70():60-5. PubMed ID: 753024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of intestinal carcinoma in the rat by x-irradiation of the small intestine.
    OSBORNE JW; NICHOLSON DP; PRASAD KN
    Radiat Res; 1963 Jan; 18():76-85. PubMed ID: 13940491
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship between the radioisotopic footpad assay and other immunological assays in tumor bearing rats.
    Mizushima Y; Takeichi N; Minami A; Kasai M; Itaya T; Yamaguchi H; Kobayashi H
    Tohoku J Exp Med; 1981 Mar; 133(3):331-7. PubMed ID: 7314087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
    Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
    J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 35. The immunobiology of ultraviolet-radiation carcinogenesis.
    Daynes RA; Burnham DK; Dewitt CW; Roberts LK; Krueger GG
    Cancer Surv; 1985; 4(1):51-99. PubMed ID: 3916083
    [No Abstract]   [Full Text] [Related]  

  • 36. Metastasis control by injection of blood lymphocytes cultured with neuraminidase-treated MT/W 449A rat mammary carcinoma.
    Watkins E; Anderson LL; Baralt OL; Heatley GJ
    J Biol Response Mod; 1984; 3(1):60-75. PubMed ID: 6707700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract]   [Full Text] [Related]  

  • 38. The local immune response to large bowel tumors.
    Bland PW
    Acta Chir Scand Suppl; 1985; 525():70-92. PubMed ID: 3161261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells.
    Kamlah F; Hänze J; Arenz A; Seay U; Hasan D; Juricko J; Bischoff B; Gottschald OR; Fournier C; Taucher-Scholz G; Scholz M; Seeger W; Engenhart-Cabillic R; Rose F
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1541-9. PubMed ID: 21621345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Augmentation of the anti-tumor activity of regional lymph node lymphocytes and spleen cells of tumor-bearing mice by culture with T cell growth factor in vitro--a comparison of the intestinal cancer model and footpad cancer model].
    Hori T; Kan N; Inamoto T; Nio Y; Ohgaki K; Kodama H; Tobe T
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):287-96. PubMed ID: 3487027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.